FI68825C - Geminala dihalogenderivat av kondenserade pyrimidin-4-oner vilka aer mellanprodukter vid framstaellning av terapeutiskt anaendbara 9-aminopyrido(1,2-a)pyrimidin- och 9-hydratsono- 6,,8,9-tetrahydro-4h-pyrido(1,2-a)pyrimidinderivat - Google Patents
Geminala dihalogenderivat av kondenserade pyrimidin-4-oner vilka aer mellanprodukter vid framstaellning av terapeutiskt anaendbara 9-aminopyrido(1,2-a)pyrimidin- och 9-hydratsono- 6,,8,9-tetrahydro-4h-pyrido(1,2-a)pyrimidinderivat Download PDFInfo
- Publication number
- FI68825C FI68825C FI801512A FI801512A FI68825C FI 68825 C FI68825 C FI 68825C FI 801512 A FI801512 A FI 801512A FI 801512 A FI801512 A FI 801512A FI 68825 C FI68825 C FI 68825C
- Authority
- FI
- Finland
- Prior art keywords
- tetrahydro
- pyrimidin
- pyrido
- methyl
- pyrimidine
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 claims description 29
- 125000000217 alkyl group Chemical group 0.000 claims description 9
- 229910052736 halogen Inorganic materials 0.000 claims description 9
- 150000002367 halogens Chemical class 0.000 claims description 9
- 239000001257 hydrogen Substances 0.000 claims description 8
- DNCYBUMDUBHIJZ-UHFFFAOYSA-N 1h-pyrimidin-6-one Chemical class O=C1C=CN=CN1 DNCYBUMDUBHIJZ-UHFFFAOYSA-N 0.000 claims description 7
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 5
- 150000002431 hydrogen Chemical group 0.000 claims description 4
- 239000000543 intermediate Substances 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Natural products N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 claims description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 2
- SYZUGBCZNVTNDG-UHFFFAOYSA-N C1CC(C2=NC=CCN2C1)NN Chemical class C1CC(C2=NC=CCN2C1)NN SYZUGBCZNVTNDG-UHFFFAOYSA-N 0.000 claims 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical group 0.000 description 48
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 44
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 39
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 38
- 229910052794 bromium Inorganic materials 0.000 description 32
- 229910052757 nitrogen Inorganic materials 0.000 description 23
- 238000000034 method Methods 0.000 description 17
- 238000003756 stirring Methods 0.000 description 17
- 229960000583 acetic acid Drugs 0.000 description 16
- 239000011541 reaction mixture Substances 0.000 description 15
- 238000006243 chemical reaction Methods 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 11
- 150000001412 amines Chemical class 0.000 description 11
- 238000004458 analytical method Methods 0.000 description 11
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 11
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 10
- 239000003795 chemical substances by application Substances 0.000 description 10
- 239000012362 glacial acetic acid Substances 0.000 description 10
- 230000002140 halogenating effect Effects 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 9
- 239000012074 organic phase Substances 0.000 description 9
- 239000001632 sodium acetate Substances 0.000 description 9
- 235000017281 sodium acetate Nutrition 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- YWLVFQUVWLTLJA-UHFFFAOYSA-N 9,9-dibromo-6-methyl-4-oxo-7,8-dihydro-6h-pyrido[1,2-a]pyrimidine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)N2C(C)CCC(Br)(Br)C2=N1 YWLVFQUVWLTLJA-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 8
- 238000002844 melting Methods 0.000 description 8
- 230000008018 melting Effects 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- CSOYDALHEQEMAK-UHFFFAOYSA-N 2h-pyrimidine-1-carboxylic acid Chemical compound OC(=O)N1CN=CC=C1 CSOYDALHEQEMAK-UHFFFAOYSA-N 0.000 description 6
- VMMMQJDPWGCLAH-UHFFFAOYSA-N C1CN2CC=CN=C2C(=C1)N Chemical class C1CN2CC=CN=C2C(=C1)N VMMMQJDPWGCLAH-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 239000008346 aqueous phase Substances 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 6
- 230000008025 crystallization Effects 0.000 description 6
- -1 cyano, carbamoyl Chemical group 0.000 description 6
- 239000000725 suspension Substances 0.000 description 6
- 239000007858 starting material Substances 0.000 description 5
- KOXNRJHZWXSKMF-UHFFFAOYSA-N 6-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)N2C(C)CCCC2=N1 KOXNRJHZWXSKMF-UHFFFAOYSA-N 0.000 description 4
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- 150000002429 hydrazines Chemical class 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- SWHJKRHVNLCDSX-UHFFFAOYSA-N 9-bromo-6-methyl-4-oxo-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)N2C(C)CCC(Br)C2=N1 SWHJKRHVNLCDSX-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- JOWRFSPJFXLGGY-UHFFFAOYSA-N rimazolium Chemical compound C1CCC(C)N2C(=O)C(C(=O)OCC)=C[N+](C)=C21 JOWRFSPJFXLGGY-UHFFFAOYSA-N 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- FVZLXIARAAOVCZ-UHFFFAOYSA-N 1h-azepine-3-carboxylic acid Chemical compound OC(=O)C1=CNC=CC=C1 FVZLXIARAAOVCZ-UHFFFAOYSA-N 0.000 description 2
- SQWSRGTXANWLLI-UHFFFAOYSA-N 3,9,9-tribromo-6-methyl-7,8-dihydro-6h-pyrido[1,2-a]pyrimidin-4-one Chemical compound C1=C(Br)C(=O)N2C(C)CCC(Br)(Br)C2=N1 SQWSRGTXANWLLI-UHFFFAOYSA-N 0.000 description 2
- HCJOGZBBWGQKGC-UHFFFAOYSA-N 6-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one Chemical compound C1=CC(=O)N2C(C)CCCC2=N1 HCJOGZBBWGQKGC-UHFFFAOYSA-N 0.000 description 2
- JSONPMDHAHNDDX-UHFFFAOYSA-N 9,9-dibromo-6-methyl-3-phenyl-7,8-dihydro-6h-pyrido[1,2-a]pyrimidin-4-one Chemical compound O=C1N2C(C)CCC(Br)(Br)C2=NC=C1C1=CC=CC=C1 JSONPMDHAHNDDX-UHFFFAOYSA-N 0.000 description 2
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical class [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 2
- WXOQPVPCAAVXOV-UHFFFAOYSA-N ethyl 4-oxo-7,8-dihydro-6h-pyrrolo[1,2-a]pyrimidine-3-carboxylate Chemical compound O=C1C(C(=O)OCC)=CN=C2CCCN21 WXOQPVPCAAVXOV-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- JGJLWPGRMCADHB-UHFFFAOYSA-N hypobromite Chemical compound Br[O-] JGJLWPGRMCADHB-UHFFFAOYSA-N 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 150000003230 pyrimidines Chemical class 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 2
- SEPPVOUBHWNCAW-FNORWQNLSA-N (E)-4-oxonon-2-enal Chemical compound CCCCCC(=O)\C=C\C=O SEPPVOUBHWNCAW-FNORWQNLSA-N 0.000 description 1
- GGMQZPIDPNAGFP-UHFFFAOYSA-N 1,1-dibromo-1,2,2,2-tetrachloroethane Chemical class ClC(Cl)(Cl)C(Cl)(Br)Br GGMQZPIDPNAGFP-UHFFFAOYSA-N 0.000 description 1
- QLAJNZSPVITUCQ-UHFFFAOYSA-N 1,3,2-dioxathietane 2,2-dioxide Chemical compound O=S1(=O)OCO1 QLAJNZSPVITUCQ-UHFFFAOYSA-N 0.000 description 1
- RHQQHZQUAMFINJ-GKWSUJDHSA-N 1-[(3s,5s,8s,9s,10s,11s,13s,14s,17s)-3,11-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-hydroxyethanone Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@H](CC4)C(=O)CO)[C@@H]4[C@@H]3CC[C@H]21 RHQQHZQUAMFINJ-GKWSUJDHSA-N 0.000 description 1
- GJNCXCPHNRATIQ-UHFFFAOYSA-N 1-bromoazepan-2-one Chemical compound BrN1CCCCCC1=O GJNCXCPHNRATIQ-UHFFFAOYSA-N 0.000 description 1
- WHTZQYDVDPHTAM-UHFFFAOYSA-N 2,2,2-tribromo-1-phenylethanone Chemical compound BrC(Br)(Br)C(=O)C1=CC=CC=C1 WHTZQYDVDPHTAM-UHFFFAOYSA-N 0.000 description 1
- QLENPRKQIFCBST-UHFFFAOYSA-N 3,6-dimethyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one Chemical compound C1=C(C)C(=O)N2C(C)CCCC2=N1 QLENPRKQIFCBST-UHFFFAOYSA-N 0.000 description 1
- NVBCFOQYDFKXJJ-UHFFFAOYSA-N 3-formyl-1h-indole-5-carbonitrile Chemical compound C1=C(C#N)C=C2C(C=O)=CNC2=C1 NVBCFOQYDFKXJJ-UHFFFAOYSA-N 0.000 description 1
- MNYZYZFHEGWREA-UHFFFAOYSA-N 4,6,7,8-tetrahydropyrido[1,2-a]pyrimidin-9-ylidenehydrazine Chemical class N(N)=C1CCCN2C1=NC=CC2 MNYZYZFHEGWREA-UHFFFAOYSA-N 0.000 description 1
- LLBZPESJRQGYMB-UHFFFAOYSA-N 4-one Natural products O1C(C(=O)CC)CC(C)C11C2(C)CCC(C3(C)C(C(C)(CO)C(OC4C(C(O)C(O)C(COC5C(C(O)C(O)CO5)OC5C(C(OC6C(C(O)C(O)C(CO)O6)O)C(O)C(CO)O5)OC5C(C(O)C(O)C(C)O5)O)O4)O)CC3)CC3)=C3C2(C)CC1 LLBZPESJRQGYMB-UHFFFAOYSA-N 0.000 description 1
- GCSPLISWBUONJD-UHFFFAOYSA-N 4H-pyrido[1,2-a]pyrimidin-9-amine Chemical compound NC1=CC=CN2C1=NC=CC2 GCSPLISWBUONJD-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- HNTWDRHOLWKXFX-UHFFFAOYSA-N 9,9-dibromo-3,6-dimethyl-7,8-dihydro-6h-pyrido[1,2-a]pyrimidin-4-one Chemical compound C1=C(C)C(=O)N2C(C)CCC(Br)(Br)C2=N1 HNTWDRHOLWKXFX-UHFFFAOYSA-N 0.000 description 1
- SPJTYWXEQRPSGQ-UHFFFAOYSA-N 9,9-dibromo-3-ethyl-2,6-dimethyl-7,8-dihydro-6h-pyrido[1,2-a]pyrimidin-4-one Chemical compound O=C1C(CC)=C(C)N=C2N1C(C)CCC2(Br)Br SPJTYWXEQRPSGQ-UHFFFAOYSA-N 0.000 description 1
- YHTRJLYVAGCNAK-UHFFFAOYSA-N 9,9-dibromo-6-methyl-7,8-dihydro-6h-pyrido[1,2-a]pyrimidin-4-one Chemical compound C1=CC(=O)N2C(C)CCC(Br)(Br)C2=N1 YHTRJLYVAGCNAK-UHFFFAOYSA-N 0.000 description 1
- QUVNGKVLPVMJEQ-UHFFFAOYSA-N 9,9-dichloro-6-methyl-4-oxo-7,8-dihydro-6h-pyrido[1,2-a]pyrimidine-3-carboxylic acid Chemical compound C1=C(C(O)=O)C(=O)N2C(C)CCC(Cl)(Cl)C2=N1 QUVNGKVLPVMJEQ-UHFFFAOYSA-N 0.000 description 1
- 101000912181 Arabidopsis thaliana Cysteine synthase, mitochondrial Proteins 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- LBGAWFWSIGIGOC-UHFFFAOYSA-N BrC1(CCC(N2C1=NC(=CC2=O)C(=O)O)C)Br Chemical compound BrC1(CCC(N2C1=NC(=CC2=O)C(=O)O)C)Br LBGAWFWSIGIGOC-UHFFFAOYSA-N 0.000 description 1
- RFGHIALNBZWTFM-UHFFFAOYSA-N C1OCCOC1.Br.Br.Br Chemical compound C1OCCOC1.Br.Br.Br RFGHIALNBZWTFM-UHFFFAOYSA-N 0.000 description 1
- ICKNRJMYVNTOGQ-UHFFFAOYSA-N CC1CCCC2=NCCC(=O)N12 Chemical group CC1CCCC2=NCCC(=O)N12 ICKNRJMYVNTOGQ-UHFFFAOYSA-N 0.000 description 1
- FMIBXGIXCGJQDE-UHFFFAOYSA-N CCC1(CCCC2=NC(=CC(=O)N21)C)C Chemical compound CCC1(CCCC2=NC(=CC(=O)N21)C)C FMIBXGIXCGJQDE-UHFFFAOYSA-N 0.000 description 1
- 229910021590 Copper(II) bromide Inorganic materials 0.000 description 1
- 229910021592 Copper(II) chloride Chemical class 0.000 description 1
- 101000760663 Hololena curta Mu-agatoxin-Hc1a Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- QZRGKCOWNLSUDK-UHFFFAOYSA-N Iodochlorine Chemical compound ICl QZRGKCOWNLSUDK-UHFFFAOYSA-N 0.000 description 1
- 101100045754 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) rtf-1 gene Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- XSHFJEGTDLOUMM-UHFFFAOYSA-N [Br-].[O-]Br(=O)(=O)=O.C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1 Chemical compound [Br-].[O-]Br(=O)(=O)=O.C1=CC=[NH+]C=C1.C1=CC=[NH+]C=C1 XSHFJEGTDLOUMM-UHFFFAOYSA-N 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- 150000001448 anilines Chemical class 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- CODNYICXDISAEA-UHFFFAOYSA-N bromine monochloride Chemical compound BrCl CODNYICXDISAEA-UHFFFAOYSA-N 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical class Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- ILYWMFFSYODXAH-UHFFFAOYSA-N ethyl 10,10-dibromo-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]azepine-3-carboxylate Chemical compound BrC1(C=2N(CCCC1)CC(=CC2)C(=O)OCC)Br ILYWMFFSYODXAH-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910001867 inorganic solvent Inorganic materials 0.000 description 1
- 239000003049 inorganic solvent Substances 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000001160 methoxycarbonyl group Chemical group [H]C([H])([H])OC(*)=O 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- VDCLSGXZVUDARN-UHFFFAOYSA-N molecular bromine;pyridine;hydrobromide Chemical compound Br.BrBr.C1=CC=NC=C1 VDCLSGXZVUDARN-UHFFFAOYSA-N 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- DDBREPKUVSBGFI-UHFFFAOYSA-N phenobarbital Chemical compound C=1C=CC=CC=1C1(CC)C(=O)NC(=O)NC1=O DDBREPKUVSBGFI-UHFFFAOYSA-N 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-O pyridinium Chemical compound C1=CC=[NH+]C=C1 JUJWROOIHBZHMG-UHFFFAOYSA-O 0.000 description 1
- 229940083082 pyrimidine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 229960000416 rimazolium Drugs 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- IXZDIALLLMRYOU-UHFFFAOYSA-N tert-butyl hypochlorite Chemical compound CC(C)(C)OCl IXZDIALLLMRYOU-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- ZNEOHLHCKGUAEB-UHFFFAOYSA-N trimethylphenylammonium Chemical compound C[N+](C)(C)C1=CC=CC=C1 ZNEOHLHCKGUAEB-UHFFFAOYSA-N 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B62/00—Reactive dyes, i.e. dyes which form covalent bonds with the substrates or which polymerise with themselves
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU79CI1932A HU179443B (en) | 1979-05-11 | 1979-05-11 | Process for producing substituted geminal dihalogeno-derivatives of pyrido-square bracket-1,2-a-square closed-pyrimidines,pyrrolo-square bracket-1,2-a-square bracket closed-pyrimidines and pyrimido-square bracket-1,2,-a-square bracket closed-asepines |
| HUCI001932 | 1979-05-11 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI801512A7 FI801512A7 (fi) | 1980-11-12 |
| FI68825B FI68825B (fi) | 1985-07-31 |
| FI68825C true FI68825C (fi) | 1985-11-11 |
Family
ID=10994747
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI801512A FI68825C (fi) | 1979-05-11 | 1980-05-09 | Geminala dihalogenderivat av kondenserade pyrimidin-4-oner vilka aer mellanprodukter vid framstaellning av terapeutiskt anaendbara 9-aminopyrido(1,2-a)pyrimidin- och 9-hydratsono- 6,,8,9-tetrahydro-4h-pyrido(1,2-a)pyrimidinderivat |
Country Status (24)
| Country | Link |
|---|---|
| JP (1) | JPS5615286A (cs) |
| AT (1) | AT377261B (cs) |
| BE (1) | BE883217A (cs) |
| CA (1) | CA1141379A (cs) |
| CH (1) | CH646971A5 (cs) |
| CS (1) | CS241025B2 (cs) |
| DD (1) | DD150605A5 (cs) |
| DE (1) | DE3017564A1 (cs) |
| DK (1) | DK204680A (cs) |
| ES (1) | ES491896A0 (cs) |
| FI (1) | FI68825C (cs) |
| FR (1) | FR2456101A1 (cs) |
| GB (1) | GB2051048B (cs) |
| GR (1) | GR68518B (cs) |
| HU (1) | HU179443B (cs) |
| IL (1) | IL59967A (cs) |
| IT (1) | IT1133085B (cs) |
| LU (1) | LU82437A1 (cs) |
| NL (1) | NL8002678A (cs) |
| NO (1) | NO152607C (cs) |
| PL (1) | PL124035B1 (cs) |
| PT (1) | PT71213A (cs) |
| SE (1) | SE441747B (cs) |
| SU (1) | SU1151210A3 (cs) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU178453B (en) * | 1979-05-11 | 1982-05-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing 9-hydrazino-4-oxo-6,7,8,9-tetrahydro-4h-p-pyrido-square bracket-1,2-a-square bracket closed-pyrimidine derivatives |
| US4395549A (en) | 1981-10-02 | 1983-07-26 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. | 6-Hydrazono-pyrido[2,1-b] quinazoline-11 ones |
| ES8501397A1 (es) * | 1982-08-05 | 1984-11-16 | Erba Farmitalia | "procedimiento para preparar derivados de quinazolina" |
| US5158952A (en) * | 1988-11-07 | 1992-10-27 | Janssen Pharmaceutica N.V. | 3-[2-[4-(6-fluoro-1,2-benzisoxozol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9 tetrahydro-9-hydroxy-2-methyl-4H-pyrido [1,2-a]pyrimidin-4-one, compositions and method of use |
| UA72189C2 (uk) | 1997-11-17 | 2005-02-15 | Янссен Фармацевтика Н.В. | Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT294107B (de) * | 1966-11-02 | 1971-11-10 | Chinoin Gyogyszer Es Vegyeszet | Verfahren zur Herstellung von neuen Homopyrimidazol-Derivaten sowie von deren Salzen |
| HU178496B (en) * | 1977-12-29 | 1982-05-28 | Chinoin Gyogyszer Es Vegyeszet | Process for preparing 6,7,8,9-tetrahydro-4h-pyrido/1,2-a/pyrimidine derivatives with antiallergic activity |
-
1979
- 1979-05-11 HU HU79CI1932A patent/HU179443B/hu unknown
-
1980
- 1980-05-01 IL IL59967A patent/IL59967A/xx unknown
- 1980-05-03 GR GR61852A patent/GR68518B/el unknown
- 1980-05-08 CS CS803258A patent/CS241025B2/cs unknown
- 1980-05-08 SE SE8003479A patent/SE441747B/sv not_active IP Right Cessation
- 1980-05-08 DE DE19803017564 patent/DE3017564A1/de not_active Withdrawn
- 1980-05-08 SU SU802920002A patent/SU1151210A3/ru active
- 1980-05-09 CA CA000351662A patent/CA1141379A/en not_active Expired
- 1980-05-09 AT AT0247580A patent/AT377261B/de not_active IP Right Cessation
- 1980-05-09 GB GB8015469A patent/GB2051048B/en not_active Expired
- 1980-05-09 CH CH366380A patent/CH646971A5/de not_active IP Right Cessation
- 1980-05-09 FI FI801512A patent/FI68825C/fi not_active IP Right Cessation
- 1980-05-09 NL NL8002678A patent/NL8002678A/nl not_active Application Discontinuation
- 1980-05-09 BE BE0/200550A patent/BE883217A/fr not_active IP Right Cessation
- 1980-05-09 NO NO801378A patent/NO152607C/no unknown
- 1980-05-09 IT IT67719/80A patent/IT1133085B/it active
- 1980-05-09 LU LU82437A patent/LU82437A1/fr unknown
- 1980-05-09 FR FR8010481A patent/FR2456101A1/fr active Granted
- 1980-05-09 JP JP6161680A patent/JPS5615286A/ja active Pending
- 1980-05-09 DK DK204680A patent/DK204680A/da not_active Application Discontinuation
- 1980-05-09 PT PT71213A patent/PT71213A/pt unknown
- 1980-05-10 PL PL1980224163A patent/PL124035B1/pl unknown
- 1980-05-12 DD DD80221053A patent/DD150605A5/de unknown
- 1980-05-12 ES ES491896A patent/ES491896A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| SE8003479L (sv) | 1980-11-12 |
| FR2456101B1 (cs) | 1985-04-05 |
| IL59967A (en) | 1984-05-31 |
| CA1141379A (en) | 1983-02-15 |
| FI68825B (fi) | 1985-07-31 |
| JPS5615286A (en) | 1981-02-14 |
| FI801512A7 (fi) | 1980-11-12 |
| NL8002678A (nl) | 1980-11-13 |
| ES8102570A1 (es) | 1981-02-16 |
| ES491896A0 (es) | 1981-02-16 |
| DK204680A (da) | 1980-11-12 |
| ATA247580A (de) | 1984-07-15 |
| BE883217A (fr) | 1980-09-01 |
| SU1151210A3 (ru) | 1985-04-15 |
| AT377261B (de) | 1985-02-25 |
| NO152607B (no) | 1985-07-15 |
| NO152607C (no) | 1985-10-23 |
| GR68518B (cs) | 1982-01-11 |
| PL124035B1 (en) | 1982-12-31 |
| LU82437A1 (fr) | 1980-07-31 |
| IL59967A0 (en) | 1980-07-31 |
| DD150605A5 (de) | 1981-09-09 |
| IT1133085B (it) | 1986-07-09 |
| SE441747B (sv) | 1985-11-04 |
| PT71213A (en) | 1980-06-01 |
| DE3017564A1 (de) | 1980-11-13 |
| FR2456101A1 (fr) | 1980-12-05 |
| IT8067719A0 (it) | 1980-05-09 |
| HU179443B (en) | 1982-10-28 |
| GB2051048A (en) | 1981-01-14 |
| GB2051048B (en) | 1983-01-19 |
| CH646971A5 (de) | 1984-12-28 |
| PL224163A1 (cs) | 1981-02-13 |
| CS241025B2 (en) | 1986-03-13 |
| CS325880A2 (en) | 1985-06-13 |
| NO801378L (no) | 1980-11-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110437124B (zh) | 一种吲哚醌衍生物的制备方法 | |
| Lamara et al. | 3H-Azepines and related systems. Part 4. Preparation of 3H-azepin-2-ones and 6H-azepino [2, 1-b] quinazolin-12-ones by photo-induced ring expansions of aryl azides | |
| EP0300614B1 (en) | Process for the preparation of substituted indolinone derivatives | |
| FI68825C (fi) | Geminala dihalogenderivat av kondenserade pyrimidin-4-oner vilka aer mellanprodukter vid framstaellning av terapeutiskt anaendbara 9-aminopyrido(1,2-a)pyrimidin- och 9-hydratsono- 6,,8,9-tetrahydro-4h-pyrido(1,2-a)pyrimidinderivat | |
| Xiong et al. | An efficient asymmetric route to eudesmane acids. Total synthesis of (+)-12-hydroxy-α-cyperone,(+)-12-oxo-α-cyperone and (+)-3-oxoeudesma-4, 11 (13)-dien-12-oic acid | |
| Forman et al. | Convenient synthesis of the 1, 4-bishomo-6-secoheptaprismane ring system | |
| IE54308B1 (en) | Chemical compounds | |
| DE60223227T2 (de) | BenzoÄbÄthiophenderivate und Verfahren zu deren Herstellung | |
| KR890003000B1 (ko) | 이미다조[1,2-a]피리미딘의 제조방법 | |
| Koebel et al. | Synthesis of thieno [2, 3-b] azepin-4-ones as potential antineoplastic agents | |
| Mbala et al. | Investigation towards an efficient synthesis of benzo [g] isoquinoline-1, 5, 10 (2H)-triones | |
| EP0273321B1 (en) | 7-bromo-beta-carboline compound and method for producing same | |
| EP0008446B1 (en) | Process for the preparation of carbazoles and novel carbazole derivatives utilized therein | |
| KR101001129B1 (ko) | 디벤즈옥세핀 유도체의 제조 방법 | |
| KR101485418B1 (ko) | 고순도 미르타자핀의 제조방법 | |
| Buñuel et al. | Z-2-phenyl-4-[(S)-2, 2-dimethyl-1, 3-dioxolan-4-ylmethylen]-5 (4H)-oxazolone as the dienophile in asymmetric diels-alder reactions. II | |
| US7109327B2 (en) | Total synthesis of galanthamine, analogues and derivatives thereof | |
| Hicks et al. | The synthesis and photochemical behaviour of some annelated tropones | |
| Maestro et al. | MIRC reactions of 2-bromo-5-(l-menthyloxy) furan-2 (5H)-one with stabilized anions. Preparation of homochiral bicyclic γ-butyrolactones | |
| Bogdanowicz-Szwed et al. | Hetero-Diels-Alder Reactions of Enaminothione with Electrophilic Olefins. Synthesis of 2-Furyl Substituted 2H-Thiopyrans | |
| JPH0227994B2 (cs) | ||
| Smith et al. | Synthetic approaches to hexahydropyrrolo [1, 2‐b] isoquinolones | |
| CN109776388B (zh) | 一种具有c2季碳中心的吲哚啉衍生物的合成方法 | |
| DD220307A5 (de) | Verfahren zur herstellung von polycyclische carbonsaeureverbindungen | |
| Furrer et al. | Conversion of 1‐benzyl‐4‐aminotetrahydropyridine‐3‐carboxylic acid methyl ester to antithrombotic pyrido [4, 3‐d] pyrimidine‐2, 4‐diones and to (2‐oxotetrahydropyrimidin‐4‐ylidene) acetic acid methyl esters |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: CHINOIN GYOGUSZER ES VEGYESZETI TERMEKEK |